Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corey Langer

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2004
Individualized patient dosing in phase I clinical trials: the role of escalation with overdose control in PNU-214936Jonathan D Cheng, James S Babb, Corey Langer, et al.
Cancer|July 6, 2017
Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancerJean-Claude M Rwigema, Vivek Verma, Liyong Lin, et al.
Lung Cancer (Amsterdam, Netherlands)|March 13, 2013
The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801Yaacov Richard Lawrence, Rebecca Paulus, Corey Langer, et al.
Head & Neck|March 5, 2004
Comparing cancer patients who enroll in a smoking cessation program at a comprehensive cancer center with those who decline enrollmentRobert A Schnoll, Randi L Rothman, Caryn Lerman, et al.
Psycho-Oncology|May 11, 2004
Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation: implications for the development of tobacco control programs for cancer patientsRobert A Schnoll, Randi L Rothman, Holly Newman, et al.
Psycho-Oncology|January 26, 2019
A randomized controlled trial of 24 weeks of varenicline for tobacco use among cancer patients: Efficacy, safety, and adherenceRobert Schnoll, Frank Leone, Anna Veluz-Wilkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panelCesare Gridelli, Matti Aapro, Andrea Ardizzoni, et al.
Clinical Lung Cancer|January 11, 2023
Toxicities and Deaths From Intercurrent Disease Following Contemporary Postoperative Radiotherapy in Resected Non-Small-Cell Lung CancerKristine N Kim, Jonathan Heintz, Nikhil Yegya-Raman, et al.
Clinical Lung Cancer|January 1, 2025
Brief Report: Osimertinib Plus Capmatinib for Patients With MET-Altered EGFR-Mutant NSCLC Following Progression on Front Line TherapyOmar Elghawy, Adam Barsouk, Lauren Reed-Guy, et al.
JAMA Oncology|September 5, 2018
Safety and Efficacy of Bevacizumab Plus Standard-of-Care Treatment Beyond Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer: The AvaALL Randomized Clinical TrialCesare Gridelli, Javier de Castro Carpeno, Anne-Marie C Dingemans, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2004
Individualized patient dosing in phase I clinical trials: the role of escalation with overdose control in PNU-214936Jonathan D Cheng, James S Babb, Corey Langer, et al.
Cancer|July 6, 2017
Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancerJean-Claude M Rwigema, Vivek Verma, Liyong Lin, et al.
Lung Cancer (Amsterdam, Netherlands)|March 13, 2013
The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801Yaacov Richard Lawrence, Rebecca Paulus, Corey Langer, et al.
Head & Neck|March 5, 2004
Comparing cancer patients who enroll in a smoking cessation program at a comprehensive cancer center with those who decline enrollmentRobert A Schnoll, Randi L Rothman, Caryn Lerman, et al.
Psycho-Oncology|May 11, 2004
Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation: implications for the development of tobacco control programs for cancer patientsRobert A Schnoll, Randi L Rothman, Holly Newman, et al.
Psycho-Oncology|January 26, 2019
A randomized controlled trial of 24 weeks of varenicline for tobacco use among cancer patients: Efficacy, safety, and adherenceRobert Schnoll, Frank Leone, Anna Veluz-Wilkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panelCesare Gridelli, Matti Aapro, Andrea Ardizzoni, et al.
Clinical Lung Cancer|January 11, 2023
Toxicities and Deaths From Intercurrent Disease Following Contemporary Postoperative Radiotherapy in Resected Non-Small-Cell Lung CancerKristine N Kim, Jonathan Heintz, Nikhil Yegya-Raman, et al.
Clinical Lung Cancer|January 1, 2025
Brief Report: Osimertinib Plus Capmatinib for Patients With MET-Altered EGFR-Mutant NSCLC Following Progression on Front Line TherapyOmar Elghawy, Adam Barsouk, Lauren Reed-Guy, et al.
JAMA Oncology|September 5, 2018
Safety and Efficacy of Bevacizumab Plus Standard-of-Care Treatment Beyond Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer: The AvaALL Randomized Clinical TrialCesare Gridelli, Javier de Castro Carpeno, Anne-Marie C Dingemans, et al.
Pageof 11